Peter Duncan, former presenter of the BBC children's programme Blue Peter, has advocated for broader access to a targeted prostate cancer treatment throughout the United Kingdom. The 72-year-old shared his personal experience with the disease, having been diagnosed in 2019 and subsequently undergoing focal therapy. This treatment involves destroying only the cancerous portion of the prostate rather than the entire gland.

Duncan described the procedure as highly effective in his case, noting that he experienced only minor side effects afterward. His positive outcome has prompted him to support efforts by Prostate Cancer UK to expand availability of the therapy to a wider patient population.

Recent research conducted by Imperial College London and Imperial College Healthcare Trust has further bolstered the argument for wider use of focal therapy. Their report indicates that the treatment’s effectiveness is comparable to traditional approaches such as radiotherapy and prostatectomy, which often involve removing or irradiating the entire prostate.

Despite these findings, focal therapy is not yet routinely offered to all eligible patients across the UK. Duncan emphasized the need to change this situation to give more men access to these potentially life-changing options.

Prostate cancer remains one of the most common cancers affecting men in the UK. Advocates argue that expanding access to less invasive treatments like focal therapy could improve quality of life outcomes while effectively managing the disease.